Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
jueves, 16 de marzo de 2017
Read about Women's History Month, Heart Health and more 2
Message from the Director
For over 100 years, FDA has supported research, policies, and outreach to protect and promote women’s health. When Congress passed the Pure Food and Drugs Act in 1906, infections were the leading causes of death and infirmity; and many women suffered due to adulterated and misbranded products. Since that time, there have been many scientific advances that have allowed women and their families to live longer and experience a better quality of life.
This Women’s History Month is a time when we can reflect on how far we have come over the years and new directions for the future. I encourage you to explore the timeline of some of FDA’s accomplishments in women’s health. I also invite you to read about the scientists, field inspectors, doctors and other women who have made notable contributions to FDA and paved the way for future generations of women in STEM. Lastly, I ask that you read this eUpdate to find ways that you too can get involved in FDA’s work. Participate in one of the upcoming workshops and public meetings highlighted here. Share the safety messages and other resources to help women make informed choices about their healthcare. Those early women pioneers showed us that our individual and collective actions can make a difference.
Marsha Henderson, Assistant Commissioner for Women’s Health
WOMEN’S HEALTH HIGHLIGHTS
Viberzi (eluxadoline): Drug Safety Communication - Increased Risk of Serious Pancreatitis In Patients Without A Gallbladder
FDA is warning that Viberzi (eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. An FDA review found these patients have an increased risk of developing serious pancreatitis that could result in hospitalization or death. Pancreatitis may be caused by spasm of a certain digestive system muscle in the small intestine. As a result, FDA is working with the Viberzi manufacturer, Allergan, to address these safety concerns.
Throughout its history, FDA has worked to protect the health of women and their families. From issuing warnings about unsafe products for pregnant women to improving mammography quality, women’s health has remained a priority for FDA. This Women’s History Month, celebrate by learning more about FDA’s historical impact on women’s health and some of the trailblazing women who helped to make that work possible.
New Blog: FDA’s Commitment to Women’s Heart Health Research
A new blog from OWH Director, Marsha Henderson, highlights the history of FDA research on QT prolongation and demonstrates the ways ongoing collaborations across FDA research programs are helping to advance policies and projects to protect women’s heart health.
FDA's Food and Cosmetic Information Center Answers Your Questions
FDA’s Food and Cosmetic Information Center (FCIC) answers questions about nutrition and the safety and accurate labeling of food, dietary supplements, and cosmetics. You can contact FCIC by phone and/or e-mail Monday through Friday, from 10 a.m. to 4 p.m. at 1-888-SAFEFOOD (1-888-723-3366) or, submit questions by filling out the online form.
ver historia personal en: www.cerasale.com.ar [dado de baja por la Cancillería Argentina por temas políticos, propio de la censura que rige en nuestro medio]//
weblog.maimonides.edu/farmacia/archives/UM_Informe_Autoevaluacion_FyB.pdf - //
weblog.maimonides.edu/farmacia/archives/0216_Admin_FarmEcon.pdf - //
www.proz.com/kudoz/english_to_spanish/art_literary/523942-key_factors.html - 65k - // www.llave.connmed.com.ar/portalnoticias_vernoticia.php?codigonoticia=17715 // www.frusculleda.com.ar/homepage/espanol/activities_teaching.htm // http://www.on24.com.ar/nota.aspx?idNot=36331 ||